Takayuki Katsube
7PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 13, 2024
Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor.Takayuki Katsube, Safwan Kezbor, Ryosuke Shimizu
|Mar 09, 2024
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor.Takayuki Katsube, Safwan Kezbor, Ryosuke Shimizu
|Oct 14, 2021
Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy Subjects.Nao Kawaguchi, Takayuki Katsube, Roger Echols
|Aug 04, 2021
Evaluation of covariate effects using variance-based global sensitivity analysis in pharmacometrics.Takayuki Katsube, Toshihiro Wajima
|Dec 01, 2020
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.Nao Kawaguchi, Takayuki Katsube, Roger Echols
|Jul 16, 2020
Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters.Takayuki Katsube, Yuji Inoue, Takahiro Fukuhara
Pageof 2
